Five Below authorizes new $600M share repurchase program

Board approves replacement program with no fixed expiration date; Q2 execution saw 311K shares repurchased at $60M.

What the filing says

Five Below's board of directors authorized a new share repurchase program on August 29, 2026, permitting the company to repurchase up to $600 million of its common stock. The new program replaces and supersedes the remaining capacity under the company's prior share repurchase program authorized on November 27, 2023. The authorization has no fixed expiration date and will remain in effect until all common stock authorized to be repurchased has been acquired or the program is otherwise replaced, suspended, or terminated.

In the second quarter of fiscal 2026 ended August 1, 2026, Five Below repurchased approximately 311,000 shares at a cost of approximately $60.0 million, translating to an average price of about $193.25 per share. The execution mechanism was not specified in this filing. The company's full-year fiscal 2026 guidance excludes the impact of future share repurchases.

This authorization reflects Five Below's confidence in its financial position and operational momentum. The company reported Q2 net sales of $1.26 billion (up 22.9% year-over-year) and raised its full-year 2026 sales and earnings outlook. With diluted weighted average shares outstanding of 55.5 million projected for the full year, the $600 million authorization represents meaningful capital allocation flexibility.

On August 29, 2026, the Board of Directors approved a new share repurchase program authorizing the repurchase of up to $600 million of the Company's common stock. The new share repurchase program replaces and supersedes the remaining capacity under the Company's prior share repurchase program authorized on November 27, 2023. — FIVE BELOW, INC 8-K filing  ·  View on SEC EDGAR →

What this means

The $600 million authorization reflects Five Below's strong cash generation and operational confidence. With 55.5 million diluted shares outstanding (per revised guidance), this authorization represents approximately 1.1% of current market capitalization (using Q2 execution prices). The new program supersedes a prior November 2023 authorization, suggesting the company has meaningfully deployed capital under that program. The company's full-year guidance explicitly excludes the impact of future repurchases, indicating that any buyback impact on EPS would reduce reported earnings per share. This is a discretionary capital allocation tool available to management rather than a committed obligation.

Frequently asked questions

When was the new $600M repurchase program authorized?

Five Below's board of directors approved the new share repurchase program on August 29, 2026. The program replaces and supersedes the remaining capacity under the company's prior program authorized on November 27, 2023.

How many shares did Five Below repurchase in Q2 2026?

The company repurchased approximately 311,000 shares in the second quarter of fiscal 2026 at a cost of approximately $60.0 million, representing an average price of about $193.25 per share.

Does the new authorization have an expiration date?

No. The new repurchase program has no fixed expiration date and will remain in effect until all common stock authorized to be repurchased has been acquired, or until the program is otherwise replaced, suspended, or terminated by the board.

How does Five Below account for repurchases in its guidance?

Five Below's full-year 2026 guidance explicitly excludes the impact of future share repurchases, if any. This means any buyback activity in the remainder of fiscal 2026 would reduce reported earnings per share relative to guidance.

What execution mechanism does Five Below use for repurchases?

The filing does not specify the execution mechanism (such as Rule 10b-18, ASR, or 10b5-1 plan) for the new program. Five Below typically discloses execution details in quarterly earnings releases and filings.

Why is Five Below repurchasing shares?

The filing does not provide an explicit rationale. However, the authorization reflects strong cash generation (evidenced by Q2 net sales of $1.26 billion and raised full-year guidance), allowing the company to return capital to shareholders while funding store expansion and operations.